COVID-19 Vaccine for Pediatric Use in Canada

Introduction

This webinar informs health care providers on COVID-19 in children and authorized COVID-19 vaccine for pediatric use in Canada.

Resources

About

The National Collaborating Centre for Infectious Diseases presents:

A Public Health Agency of Canada (PHAC) COVID-19 Vaccines webinar for Health Care Providers (HCPs).

This moderated webinar will include a presentation and discussion with live Q&A to inform health care and vaccine providers on COVID-19 in children and authorized COVID-19 vaccine for pediatric use in Canada.

Resources

Discussion Topics

At the end of this webinar, participants will be able to:

  • Identify the factors that parents or guardians should consider when deciding on COVID-19 vaccination for children aged 5-11 years.
  • Describe the COVID-19 pandemic among children 5-11 years of age in Canada.
  • Summarize the clinical trial information available on the COVID-19 vaccine authorized in children 5-11 years of age.
  • Explain NACI recommendations for children 5-11 years of age.

Moderator

Dr. Joanne Embree, MSc, MD, FRCPC. Professor, Department of Pediatrics and Child Health, Department of Medical Microbiology and Infectious Diseases, University of Manitoba.

Presenters

Dr. Anne Pham-Huy, MD, FRCPC, Pediatric Infectious Diseases Specialist, CHEO. Assistant Professor, University of Ottawa

Dr. Marina Salvadori, MD, FRCPC. Clinical Lead, COVID-19, Public Health Agency of Canada

Dr. Nicole Forbes, Ph.D., NACI Secretariat, Public Health Agency of Canada